Purchase Order 36C24E22P0258

Award Date 9/30/22
Potential Completion Date 1/31/23
Potential Value $354K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $470,708 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for the delivery of an Illumina NextSeq 2000 Sequencing System to the VA Boston Healthcare System Research and Development Department. The original solicitation sought offers for this sequencing system or compatible alternatives, noting the need for compatibility with existing...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $338,350 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for the delivery of a NextSeq 2000 Sequencing System to support the Cleveland VA Medical Center Research Service's role in the VA's national sequencing mission project. According to the original special notice solicitation, this sequencing system is required to maintain data...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed price purchase order to Illumina, Inc. for a NextSeq 550DX Sequencing System and associated supplies. This sole-source award was made on September 17, 2019, with a potential value of $342,242.72 and a completion date of September 16, 2020. Illumina is a manufacturer of genomic sequencing and analysis instruments and reagents, and has previously provided similar products and services to federal agencies like...
This federal contract award is for the purchase of a NEXTSEQ 550 SEQUENCING SYSTEM by the Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The firm fixed-price contract, valued at $354,024.55, does not have a set-aside designation. Illumina has provided similar sequencing systems and consumables to other federal agencies such as the National Institutes of...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for maintenance services on an Illumina NextSeq 2000 system at the Iowa City VA Health Care System. The $137,768.16 contract has a period of performance through November 10, 2027. Illumina has previously provided sequencing systems, consumables, and support services to federal agencies including the NIH, CDC, USDA, and VA...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs Network Contracting Office 6 to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related consumables. The $384,664 contract is for the provision of a NextSeq 2000 sequencing system, support plan, and installation services. The system will be used to perform whole genome sequencing of SARS-CoV-2, whole exome sequencing, single-cell RNA sequencing, miRNA sequencing, small RNA...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 (VA - VHA VISN 23) awarded a $44,352 firm fixed price purchase order to Illumina, Inc. to provide a NEXTSEQ 2000 SILVER SERVICE PLAN. This service plan is for the period of November 11, 2023 through November 10, 2024 and will support the sequencing systems and services at VA facilities in Iowa City, Iowa. Illumina will deliver maintenance and technical support for the NEXTSEQ 2000...
The Department of Veterans Affairs (VA) awarded a $449,999.98 firm fixed price contract to Illumina, Inc., a manufacturer of DNA sequencing equipment, to provide a specialized Illumina NextSeq 550 DNA Sequencing system. This sole source contract was awarded without a set-aside designation, leveraging Illumina's patented and proprietary technology that the agency determined was the only option to meet their requirements. The contract was awarded to support the VA Boston Healthcare System's...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 (VA - VHA VISN 23) awarded a $334,594.75 firm fixed price purchase order to Illumina, Inc. to deliver a next generation sequencing system. The sequencing system will support massively parallel sequencing of DNA and RNA samples with throughput of 100-400 million reads per run and targeted resequencing panels in oncology, as requested in Solicitation 6640. The sequencing system, installation,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA - VHA VISN 2) awarded a $335,250 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 2000 Sequencing System. The solicitation sought to sole source this acquisition to support COVID sequencing efforts at the James J. Peters VA Medical Center. The Research department requires this sequencing instrument to conduct analysis of COVID samples. No subcontractors or set aside...

The Department of Veterans Affairs Veterans Health Administration awarded a $353,760 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for the delivery of a NEXTSEQ 2000 sequencing system to the Iowa City VA Health Care System Research facility. The original solicitation sought a sequencing system capable of running whole genomes, exomes, transcriptomes, and single cell libraries in a single 24-48 hour run, meeting specified throughput and coverage metrics. The requirement specifically called for the system to sequence one or two exomes or transcriptomes using a mid-output flow cell within 24 hours and include a minimum 12-month warranty. The contract period of performance runs from September 30, 2022 through January 31, 2023. No subcontractors or set-asides were identified. The sequencing system will support genomic research activities at the VA facility.

Generated 12/29/23, 2:31 PM